Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Shanghai Kinetic Medical Pays $87 Million for Jiangsu Ideal

publication date: Nov 13, 2013

Shanghai Kinetic Medical Co. acquired an 80% stake in Jiangsu Ideal Medical Science & Technology for 528 million RMB ($86.7 million). Jiangsu Ideal produces orthopedic implants, including trauma and spine implants, along with surgical instruments for orthopedic procedures. KMC is also in the orthopedics market. Its major products allow a surgeon to treat compression fractures of a vertebra in a minimally invasive outpatient procedure. More details....

Stock Symbol: (SHE: 300326)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital